216 related articles for article (PubMed ID: 31840727)
1. Mitochondria-targeted tetrahedral DNA nanostructures for doxorubicin delivery and enhancement of apoptosis.
Yan J; Chen J; Zhang N; Yang Y; Zhu W; Li L; He B
J Mater Chem B; 2020 Jan; 8(3):492-503. PubMed ID: 31840727
[TBL] [Abstract][Full Text] [Related]
2. Folate-mediated mitochondrial targeting with doxorubicin-polyrotaxane nanoparticles overcomes multidrug resistance.
Wang H; Yin H; Yan F; Sun M; Du L; Peng W; Li Q; Feng Y; Zhou Y
Oncotarget; 2015 Feb; 6(5):2827-42. PubMed ID: 25605018
[TBL] [Abstract][Full Text] [Related]
3. Algerian Propolis Potentiates Doxorubicin Mediated Anticancer Effect Against Human Pancreatic PANC-1 Cancer Cell Line through Cell Cycle Arrest, Apoptosis Induction and P-Glycoprotein Inhibition.
Rouibah H; Kebsa W; Lahouel M; Zihlif M; Ahram M; Aburmeleih B; Mustafa E; Al-Ameer HJ
Anticancer Agents Med Chem; 2018; 18(3):375-387. PubMed ID: 29318976
[TBL] [Abstract][Full Text] [Related]
4. Chitosan Immobilization on Bio-MOF Nanostructures: A Biocompatible pH-Responsive Nanocarrier for Doxorubicin Release on MCF-7 Cell Lines of Human Breast Cancer.
Abazari R; Mahjoub AR; Ataei F; Morsali A; Carpenter-Warren CL; Mehdizadeh K; Slawin AMZ
Inorg Chem; 2018 Nov; 57(21):13364-13379. PubMed ID: 30351060
[TBL] [Abstract][Full Text] [Related]
5. Rational Construction of a Mitochondrial Targeting, Fluorescent Self-Reporting Drug-Delivery Platform for Combined Enhancement of Endogenous ROS Responsiveness.
Li J; Wei YJ; Yang XL; Wu WX; Zhang MQ; Li MY; Hu ZE; Liu YH; Wang N; Yu XQ
ACS Appl Mater Interfaces; 2020 Jul; 12(29):32432-32445. PubMed ID: 32573194
[TBL] [Abstract][Full Text] [Related]
6. Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231.
Aroui S; Brahim S; De Waard M; Bréard J; Kenani A
Cancer Lett; 2009 Nov; 285(1):28-38. PubMed ID: 19523755
[TBL] [Abstract][Full Text] [Related]
7. Self-assembling doxorubicin-tocopherol succinate prodrug as a new drug delivery system: synthesis, characterization, and in vitro and in vivo anticancer activity.
Duhem N; Danhier F; Pourcelle V; Schumers JM; Bertrand O; Leduff CS; Hoeppener S; Schubert US; Gohy JF; Marchand-Brynaert J; Préat V
Bioconjug Chem; 2014 Jan; 25(1):72-81. PubMed ID: 24328289
[TBL] [Abstract][Full Text] [Related]
8. Amphiphilic dendritic nanomicelle-mediated co-delivery of 5-fluorouracil and doxorubicin for enhanced therapeutic efficacy.
Han R; Sun Y; Kang C; Sun H; Wei W
J Drug Target; 2017 Feb; 25(2):140-148. PubMed ID: 27356094
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Peptide Amphiphile as a Drug Carrier with ATP-Triggered Release for Synergistic Effect, Improved Therapeutic Index, and Penetration of 3D Cancer Cell Spheroids.
Lu S; Zhao F; Zhang Q; Chen P
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30223518
[TBL] [Abstract][Full Text] [Related]
10. The therapeutic response to multifunctional polymeric nano-conjugates in the targeted cellular and subcellular delivery of doxorubicin.
Xiong XB; Ma Z; Lai R; Lavasanifar A
Biomaterials; 2010 Feb; 31(4):757-68. PubMed ID: 19818492
[TBL] [Abstract][Full Text] [Related]
11. Enhanced Cytotoxicity of Folic Acid-Targeted Liposomes Co-Loaded with C6 Ceramide and Doxorubicin: In Vitro Evaluation on HeLa, A2780-ADR, and H69-AR Cells.
Sriraman SK; Pan J; Sarisozen C; Luther E; Torchilin V
Mol Pharm; 2016 Feb; 13(2):428-37. PubMed ID: 26702994
[TBL] [Abstract][Full Text] [Related]
12. Bioinspired polynorepinephrine nanoparticles as an efficient vehicle for enhanced drug delivery.
Lu Z; Douek AM; Rozario AM; Tabor RF; Kaslin J; Follink B; Teo BM
J Mater Chem B; 2020 Feb; 8(5):961-968. PubMed ID: 31922181
[TBL] [Abstract][Full Text] [Related]
13. Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma.
Buondonno I; Gazzano E; Jean SR; Audrito V; Kopecka J; Fanelli M; Salaroglio IC; Costamagna C; Roato I; Mungo E; Hattinger CM; Deaglio S; Kelley SO; Serra M; Riganti C
Mol Cancer Ther; 2016 Nov; 15(11):2640-2652. PubMed ID: 27466354
[TBL] [Abstract][Full Text] [Related]
14. Tumor-Penetrating Peptide-Modified DNA Tetrahedron for Targeting Drug Delivery.
Xia Z; Wang P; Liu X; Liu T; Yan Y; Yan J; Zhong J; Sun G; He D
Biochemistry; 2016 Mar; 55(9):1326-31. PubMed ID: 26789283
[TBL] [Abstract][Full Text] [Related]
15. Multi-stimuli responsive nanosystem modified by tumor-targeted carbon dots for chemophototherapy synergistic therapy.
Wang X; Li X; Mao Y; Wang D; Zhao Q; Wang S
J Colloid Interface Sci; 2019 Sep; 552():639-650. PubMed ID: 31173992
[TBL] [Abstract][Full Text] [Related]
16. Activatable Fluorescence Imaging and Targeted Drug Delivery via Extracellular Vesicle-Like Porous Coordination Polymer Nanoparticles.
Wu Y; Zhang F; Wang K; Luo P; Wei Y; Liu S
Anal Chem; 2019 Nov; 91(21):14036-14042. PubMed ID: 31603308
[TBL] [Abstract][Full Text] [Related]
17. Doxorubicin-loaded natural daptomycin micelles with enhanced targeting and anti-tumor effect in vivo.
Guo Q; Zhang L; He M; Jiang X; Tian J; Li Q; Liu Z; Wang L; Sun H
Eur J Med Chem; 2021 Oct; 222():113582. PubMed ID: 34126458
[TBL] [Abstract][Full Text] [Related]
18. VCPA, a novel synthetic derivative of α-tocopheryl succinate, sensitizes human gastric cancer to doxorubicin-induced apoptosis via ROS-dependent mitochondrial dysfunction.
Wu H; Liu S; Gong J; Liu J; Zhang Q; Leng X; Zhang N; Li Y
Cancer Lett; 2017 May; 393():22-32. PubMed ID: 28216375
[TBL] [Abstract][Full Text] [Related]
19. Enriching lipid nanovesicles with short-chain glucosylceramide improves doxorubicin delivery and efficacy in solid tumors.
van Lummel M; van Blitterswijk WJ; Vink SR; Veldman RJ; van der Valk MA; Schipper D; Dicheva BM; Eggermont AM; ten Hagen TL; Verheij M; Koning GA
FASEB J; 2011 Jan; 25(1):280-9. PubMed ID: 20876209
[TBL] [Abstract][Full Text] [Related]
20. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]